The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Caffeine acts through neuronal adenosine A 2A receptors to prevent mood and memory dysfunction triggered by chronic stress
Open accessAbstract
Significance: Epidemiological studies show that individuals exposed to repeated stress, a major trigger of depression, increase their caffeine intake, which correlates inversely with the incidence of depression. However, the mechanism underlying this protective effect is unknown. We used an animal model of chronic unpredictable stress (CUS) to show that caffeine prevents the maladaptive changes caused by CUS in a manner mimicked by the selective blockade of adenosine A 2A receptors (A 2A R). CUS enhanced A 2A R in synapses, and the selective elimination of neuronal A 2A R abrogated CUS modifications. Moreover, A 2A R blockade also afforded a therapeutic benefit, paving the way to consider A 2A R blockers as a strategy to manage the negative impact of chronic stress on mood and memory.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Moreover, animal experiments have demonstrated that A 2A R are upregulated in chronic stress animal models. 102”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [102]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Physiology and neurobiology of stress and adaptation: central role of the brain
McEwen, B. S. (2007) · Physiological Reviews · doi:10.1152/physrev.00041.2006 · Cited by 5,429 · cited 6×
“Compared with nonstressed (control) mice (noncheckered bars), the mice subjected to CUS (checkered bars) displayed increased immobility in the forced-swimming test [F(2,36) = 182.”
BackgroundResultInfluentialStress and the brain: from adaptation to disease
de Kloet, E. R., Joëls, M., & Holsboer, F. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1683 · Cited by 4,621
Willner, P. (1997) · Psychopharmacology · doi:10.1007/s002130050456 · Cited by 1,832
Synaptic Dysfunction in Depression: Potential Therapeutic Targets
Duman, R. S., & Aghajanian, G. K. (2012) · Science · doi:10.1126/science.1222939 · Cited by 1,651 · cited 2×
“However, the data are compatible with A2AR having a key role in glutamatergic terminals defining the synaptic dysfunction underlying the behavioral alterations associated with repeated stress (26, 27).”
The stressed hippocampus, synaptic plasticity and lost memories
Kim, J. J., & Diamond, D. M. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn849 · Cited by 1,543
The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission
Popoli, M., Yan, Z., McEwen, B. S., & Sanacora, G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3138 · Cited by 1,393
Sousa, N., Lukoyanov, N. V., Madeira, M. D., Almeida, O. F. X., & Paula-Barbosa, M. M. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00050-6 · Cited by 758
Fredholm, B. B., Chen, J., Cunha, R. A., Svenningsson, P., & Vaugeois, J. (2005) · International review of neurobiology · doi:10.1016/s0074-7742(05)63007-3 · Cited by 721
Self-citationNeuroprotection by adenosine in the brain: From A1 receptor activation to A2A receptor blockade
Cunha, R. A. (2005) · Purinergic Signalling · doi:10.1007/s11302-005-0649-1 · Cited by 555
Self-citationChronic stress alters synaptic terminal structure in hippocampus
Magariños, A. M., Verdugo, J. M. G., & McEwen, B. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.14002 · Cited by 543
Cited by
Sorted by citations
Major depressive disorder: hypothesis, mechanism, prevention and treatment
Cui, L., Li, S., Wang, S., Wu, X., Liu, Y., Yu, W., Wang, Y., Tang, Y., Xia, M., & Li, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01738-y · Cited by 1,244
“102 Additionally, neuronal A1 receptors exhibit hypofunction caused by a decrease in astrocyte-derived adenosine levels; 103 this decrease, as well as depressive-like behavior, can be reversed by certain antidepressants.”
BackgroundPharmacology of Adenosine Receptors: The State of the Art
Borea, P. A., Gessi, S., Merighi, S., Vincenzi, F., & Varani, K. (2018) · Physiological Reviews · doi:10.1152/physrev.00049.2017 · Cited by 783
How does adenosine control neuronal dysfunction and neurodegeneration?
Cunha, R. A. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13724 · Cited by 456
Self-citationPurinergic Signalling: Therapeutic Developments
Burnstock, G. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00661 · Cited by 422
Date Palm Tree (Phoenix dactylifera L.): Natural Products and Therapeutic Options
Al-Alawi, R. A., Al-Mashiqri, J. H., Al-Nadabi, J. S. M., Al-Shihi, B. I., & Baqi, Y. (2017) · Frontiers in Plant Science · doi:10.3389/fpls.2017.00845 · Cited by 336
Self-citationThe neuroprotective effects of caffeine in neurodegenerative diseases
Kolahdouzan, M., & Hamadeh, M. J. (2017) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12684 · Cited by 323
Du Preez, A., Onorato, D., Eiben, I., Musaelyan, K., Egeland, M., Zunszain, P. A., Fernandes, C., Thuret, S., & Pariante, C. M. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.07.015 · Cited by 285
da Silva, S. V., Haberl, M. G., Zhang, P., Bethge, P., Lemos, C., Gonçalves, N., Gorlewicz, A., Malézieux, M., Gonçalves, F. Q., Grosjean, N., et al. (2016) · Nature Communications · doi:10.1038/ncomms11915 · Cited by 254
Self-citationChen, J., & Cunha, R. A. (2020) · Purinergic Signalling · doi:10.1007/s11302-020-09694-2 · Cited by 230
Self-citationCaffeine as a factor influencing the functioning of the human body-friend or foe?
Rodak, K., Kokot, I., & Kratz, E. M. (2021) · Nutrients · doi:10.3390/nu13093088 · Cited by 188
Depression as a Glial-Based Synaptic Dysfunction
Rial, D., Lemos, C., Pinheiro, H., Duarte, J. M., Gonçalves, F. Q., Real, J. I., Prediger, R. D., Gonçalves, N., Gomes, C. A., Canas, P. M., et al. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00521 · Cited by 193
Self-citationTemido‐Ferreira, M., Ferreira, D. G., Batalha, V. L., Marques-Morgado, I., Coelho, J. E., Pereira, P., Gomes, R., Pinto, A., Carvalho, S., Canas, P. M., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0110-9 · Cited by 194
Self-citationInternational Union of Basic and Clinical Pharmacology. CXII: Adenosine Receptors: A Further Update
IJzerman, A. P., Jacobson, K. A., Müller, C. E., Cronstein, B. N., & Cunha, R. A. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000445 · Cited by 169
Self-citationUllrich (2018) · doi:10.1038/mp.2017.188 · Cited by 145
The role of adenosine receptors in mood and anxiety disorders
van Calker, D., Biber, K. P. H., Domschke, K., & Serchov, T. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14841 · Cited by 146
Glial Contribution to Excitatory and Inhibitory Synapse Loss in Neurodegeneration
Henstridge, C. M., Tzioras, M., & Paolicelli, R. C. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00063 · Cited by 155
Astrocyte Ca 2+ -evoked ATP release regulates myelinated axon excitability and conduction speed
Lezmy, J., Arancibia‐Cárcamo, I. L., Quintela‐López, T., Sherman, D. L., Brophy, P., & Attwell, D. (2021) · Science · doi:10.1126/science.abh2858 · Cited by 135
Han, L., Kong, D. K., Zheng, M.-Q., Murikinati, S., Ma, C., Yuan, P., Li, L., Tian, D., Cai, Q., Ye, C., et al. (2016) · ACS Nano · doi:10.1021/acsnano.5b07573 · Cited by 122
Pathological overproduction: the bad side of adenosine
Borea, P. A., Gessi, S., Merighi, S., Vincenzi, F., & Varani, K. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13763 · Cited by 118
López‐Cruz, L., Salamone, J. D., & Correa, M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00526 · Cited by 123
Lopes, J. P., Pliássova, A., & Cunha, R. A. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.06.008 · Cited by 122
Self-citationAdenosine A2A receptor antagonists: from caffeine to selective non‐xanthines
Jacobson, K. A., Gao, Z., Matricon, P. G., Eddy, M. T., & Carlsson, J. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15103 · Cited by 124
Caffeine Induces Neurobehavioral Effects through Modulating Neurotransmitters
Alasmari, F. (2020) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2020.02.005 · Cited by 113
“mice exposed to chronic (3 weeks) unpredictable stress (CUS) and that caffeine drinking (1 g/L), starting 3 weeks before and during CUS could inhibit these alterations (Kaster et al., 2015).”
Impact of Coffee and Cacao Purine Metabolites on Neuroplasticity and Neurodegenerative Disease
Camandola, S., Plick, N., & Mattson, M. P. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2492-0 · Cited by 111
Plant-Derived Antioxidants Protect the Nervous System From Aging by Inhibiting Oxidative Stress
Cui, X., Lin, Q.-L., & Liang, Y. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00209 · Cited by 95
Gonçalves, F. Q., Lopes, J. P., Silva, H. B. L., Lemos, C., Silva, A. C., Gonçalves, N., Tomé, Â. R., Ferreira, S. G., Canas, P. M., Rial, D., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104570 · Cited by 106
Self-citationCoffee provides a natural multitarget pharmacopeia against the hallmarks of cancer
Gaascht, F., Dicato, M. A., & Diederich, M. F. (2015) · Genes & Nutrition · doi:10.1007/s12263-015-0501-3 · Cited by 97
Al Bahhawi, T., Albasheer, O. B., Makeen, A. M., Arishi, A., Hakami, O., Maashi, S., Al-Khairat, H. K., Alganmy, O., Sahal, Y., Sharif, A., et al. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s182744 · Cited by 94
Carvalho, K., Faivre, É., Pietrowski, M. J., Marques, X., Gómez‐Murcia, V., Deleau, A., Huin, V., Hansen, J. N., Kozlov, S. O., Danis, C., et al. (2019) · Brain · doi:10.1093/brain/awz288 · Cited by 99
Wadhwa, M., Chauhan, G., Roy, K., Sahu, S., Deep, S., Jain, V., Kishore, K., Ray, K., Thakur, L., & Panjwani, U. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00049 · Cited by 94
Purinergic receptors in psychiatric disorders
Krügel, U. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.032 · Cited by 96
Adenosine A2A Receptors in the Amygdala Control Synaptic Plasticity and Contextual Fear Memory
Simões, A. P., Machado, N. J., Gonçalves, N., Kaster, M. P., Simões, A. T., Nunes, A. F., de Almeida, L. P., Goosens, K. A., Rial, D., & Cunha, R. A. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.98 · Cited by 93
Self-citationIstradefylline reduces memory deficits in aging mice with amyloid pathology
Orr, A. G., Lo, I., Schumacher, H., Ho, K., Gill, M., Guo, W., Kim, D. H., Knox, A., Saito, T., Saido, T. C., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.10.014 · Cited by 87
Jeremic, D., Sanchez-Rodriguez, I., Jimenez-Diaz, L., & Navarro-Lopez, J. D. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107808 · Cited by 89
Faivre, É., Coelho, J. E., Zornbach, K., Malik, E. M., Baqi, Y., Schneider, M., Cellai, L., Carvalho, K., Sebda, S., Figeac, M., et al. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00235 · Cited by 93
Self-citationCaetano, L. M., Pinheiro, H., Patrício, P., Mateus‐Pinheiro, A., Alves, N. D., Coimbra, B., Baptista, F. I., Henriques, S. N., Cunha, C., Santos, A. R. S., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.173 · Cited by 91
Self-citationSilva, A. C., Lemos, C., Gonçalves, F. Q., Pliássova, A., Machado, N. J., Silva, H. B. L., Canas, P. M., Cunha, R. A., Lopes, J. P., & Agostinho, P. M. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.05.024 · Cited by 90
Self-citationConvergence of adenosine and GABA signaling for synapse stabilization during development
Castro, F. G., Zappettini, S., Pressey, J. C., Silva, C. G., Russeau, M., Gervasi, N., Figueiredo, M., Montmasson, C., Renner, M. L., Canas, P. M., et al. (2021) · Science · doi:10.1126/science.abk2055 · Cited by 83
Self-citationMadeira, M. H., Boia, R., Ambrósio, A. F., & Santiago, A. R. (2017) · Mediators of Inflammation · doi:10.1155/2017/4761081 · Cited by 87
Hollnagel, J., Elzoheiry, S., Gorgas, K., Kins, S., Beretta, C. A., Kirsch, J., Kuhse, J., Kann, O., & Kiss, É. (2019) · PLoS ONE · doi:10.1371/journal.pone.0209228 · Cited by 84
Role of Adenosine in Epilepsy and Seizures
Tescarollo, F. C., Rombo, D. M., DeLiberto, L. K., Fedele, D., Alharfoush, E., Tomé, Â. R., Cunha, R. A., Sebastião, A. M., & Boison, D. (2020) · Journal of Caffeine and Adenosine Research · doi:10.1089/caff.2019.0022 · Cited by 80
Self-citationThe Role of Adenosine Signaling in Headache: A Review
Fried, N. T., Elliott, M. B., & Oshinsky, M. L. (2017) · Brain Sciences · doi:10.3390/brainsci7030030 · Cited by 77
Purine nucleosides in neuroregeneration and neuroprotection
Ribeiro, F. F., Xapelli, S., Miranda‐Lourenço, C., Tanqueiro, S. R., Fonseca‐Gomes, J., Diógenes, M. J., Ribeiro, J. A., & Sebastião, A. M. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.11.006 · Cited by 75
Yang, Y., Ju, W., Zhang, H., & Sun, L. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00229 · Cited by 83
Canas, P. M., Porciúncula, L. O., Simões, A. P., Augusto, E., Silva, H. B. L., Machado, N. J., Gonçalves, N., Alfaro, T. M., Gonçalves, F. Q., Araújo, I. M., et al. (2018) · eNeuro · doi:10.1523/eneuro.0385-18.2018 · Cited by 79
Self-citationHabitual coffee drinkers display a distinct pattern of brain functional connectivity
Magalhães, R. J. D. S., Picó‐Pérez, M., Esteves, M., Vieira, R., Castanho, T. C., Amorim, L., Sousa, M. M., Coelho, A., Fernandes, H. M., Cabral, J., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01075-4 · Cited by 81
Wang, M., Li, P., Li, Z., da Silva, B. S., Zheng, W., Xiang, Z., He, Y., Xu, T., Cordeiro, C., Deng, L., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37601-x · Cited by 73
Self-citationAstrocytes and major depression: The purinergic avenue
Zhao, Y. F., Verkhratsky, A., Tang, Y. C., & Illés, P. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109252 · Cited by 76
Adenosine A2A receptor as potential therapeutic target in neuropsychiatric disorders
Domenici, M. R., Ferrante, A., Martire, A., Chiodi, V., Pepponi, R., Tebano, M. T., & Popoli, P. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104338 · Cited by 74
Pasquini, S., Contri, C., Merighi, S., Gessi, S., Borea, P. A., Varani, K., & Vincenzi, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031219 · Cited by 72
The Pharmacological Potential of Adenosine A2A Receptor Antagonists for Treating Parkinson’s Disease
Mori, A., Chen, J., Uchida, S., Durlach, C., King, S. M., & Jenner, P. G. (2022) · Molecules · doi:10.3390/molecules27072366 · Cited by 67
Self-citationPurinergic signalling and brain development
Rodrigues, R. J., Marques, J. M., & Cunha, R. A. (2018) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2018.12.001 · Cited by 72
Self-citationSantos, V. V. D., Stark, R., Rial, D., Silva, H. B. L., Bayliss, J., Lemus, M. B., Davies, J. S., Cunha, R. A., Prediger, R. D., & Andrews, Z. B. (2017) · Journal of Neuroendocrinology · doi:10.1111/jne.12476 · Cited by 66
Self-citationBoia, R., Elvas, F., Madeira, M. H., Aires, I. D., Rodrigues‐Neves, A. C., Tralhão, P., Szabó, E. C., Baqi, Y., Müller, C. E., Tomé, Â. R., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.451 · Cited by 64
Self-citationPurinergic Signaling and Related Biomarkers in Depression
Bartoli, F., Burnstock, G., Crocamo, C., & Carrà, G. (2020) · Brain Sciences · doi:10.3390/brainsci10030160 · Cited by 64
Szopa, A., Poleszak, E., Wyska, E., Serefko, A., Wośko, S., Właź, A., Pieróg, M., Wróbel, A., & Właź, P. (2015) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-015-1189-z · Cited by 63
Potentiation of cannabinoid signaling in microglia by adenosine A2A receptor antagonists
Franco, R., Reyes‐Resina, I., Aguinaga, D., Lillo, A., Jiménez, J., Raïch, I., Borroto‐Escuela, D. O., Ferreiro‐Vera, C., Canela, E. I., de Medina, V. S., et al. (2019) · Glia · doi:10.1002/glia.23694 · Cited by 60
Machado, N. J., Simões, A. P., Silva, H. B. L., Ardais, A. P., Kaster, M. P., Garção, P., Rodrigues, D. I., Pochmann, D., Santos, A. I., Araújo, I. M., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9774-9 · Cited by 60
Self-citationAssociations Between Caffeine Consumption, Cognitive Decline, and Dementia: A Systematic Review
Chen, J. Q. A., Scheltens, P., Groot, C., & Ossenkoppele, R. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-201069 · Cited by 62
Self-citationKöles, L., Kató, E., Hanuska, A., Zádori, Z., Al‐Khrasani, M., Zelles, T., Rubini, P., & Illés, P. (2015) · Purinergic Signalling · doi:10.1007/s11302-015-9480-5 · Cited by 60
Romualdo, G. R., Bartolomeu, A. R., Vinken, M., Cogliati, B., Moreno, F. S., García, M. Á., & Barbisan, L. F. (2019) · Food Research International · doi:10.1016/j.foodres.2019.05.029 · Cited by 62
Hu, Q., Ren, X., Liu, Y., Li, Z., Zhang, L., Chen, X., He, C., & Chen, J. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.05.040 · Cited by 56
Self-citationPalmitoylation as a Functional Regulator of Neurotransmitter Receptors
Naumenko, V. S., & Ponimaskin, E. G. (2018) · Neural Plasticity · doi:10.1155/2018/5701348 · Cited by 55
Poleszak, E., Szopa, A., Bogatko, K., Wyska, E., Wośko, S., Świąder, K., Doboszewska, U., Właź, A., Wróbel, A., Właź, P., et al. (2018) · Neurotoxicity Research · doi:10.1007/s12640-018-9959-2 · Cited by 54
Duarte, J. M. N., Skoug, C., Silva, H. B. L., Carvalho, R. A., Rolf Gruetter, A., & Cunha, R. A. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.01015 · Cited by 54
Self-citationChen, T., Cheng, L., Ma, J., Yuan, J., Pi, C., Xiong, L., Chen, J., Liu, H., Tang, J., Zhong, Y., et al. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106837 · Cited by 59
Self-citationWadhwa, M., Sahu, S., Kumari, P., Kauser, H., Ray, K., & Panjwani, U. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.08.002 · Cited by 53
Zhao, Z., Zhao, Y., Ning, Y.-L., Yang, N., Peng, Y., Li, P., Chen, X.-Y., Liu, D., Wang, H., Chen, X., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.98 · Cited by 55
Self-citationOh, N. S., Joung, J. Y., Lee, J. Y., Song, J. G., Oh, S., Kim, Y., Kim, H. W., & Kim, S. H. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1756690 · Cited by 52
Oliveira, S. M., Ardais, A. P., Bastos, C. R., Gazal, M., Jansen, K., Souza, L. D. D. M., da Silva, R. A., Kaster, M. P., Lara, D. R., & Ghisleni, G. (2018) · Purinergic Signalling · doi:10.1007/s11302-018-9635-2 · Cited by 54
Self-citationLi, Z., Chen, X., Wang, T., Gao, Y., Li, F. Y., Chen, L., Xue, J., He, Y., Li, Y., Guo, W. M., et al. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.07.017 · Cited by 49
Self-citationNovel Players in the Aging Synapse: Impact on Cognition
Temido‐Ferreira, M., Coelho, J. E., Pousinha, P. A., & Lopes, L. V. (2019) · Journal of Caffeine and Adenosine Research · doi:10.1089/caff.2019.0013 · Cited by 57
Peng, G., Yang, L., Wu, C., Zhang, L. L., Wu, C. Y., Fan, L., Shi, H. W., Hou, J., Zhang, L. M., Ma, X., et al. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104926 · Cited by 50
Lv, X., Lv, S., Wang, G., Chang, Y., Cai, Y., Liu, H.-Z., Xu, G.-Z., Xu, W., & Zhang, Y. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.01.012 · Cited by 48
Fernandes, M. Y. S. D., Dobrachinski, F., Silva, H. B. L., Lopes, J. P., Gonçalves, F. Q., Soares, F. A. A., Porciúncula, L. O., de Andrade, G. M., Cunha, R. A., & Tomé, Â. R. (2021) · Scientific Reports · doi:10.1038/s41598-021-89964-0 · Cited by 48
Self-citationFernandes, L. M. P., Cartágenes, S. C., Barros, M. A., Carvalheiro, T. C. V. S., Castro, N. C. F., Schamne, M. G., Lima, R. R., Prediger, R. D., Monteiro, M. C., Fontes-Júnior, E. A., et al. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.05.007 · Cited by 46
Self-citationTargeting astrocytes in bipolar disorder
Peng, L., Li, B., & Verkhratsky, A. (2016) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2016.1171144 · Cited by 45
Schepici, G., Silvestro, S., Bramanti, P., & Mazzon, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134766 · Cited by 48
van Waarde, A., Dierckx, R., Zhou, X., Khanapur, S., Tsukada, H., Ishiwata, K., Luurtsema, G., de Vries, E. F. J., & Elsinga, P. H. (2017) · Medicinal Research Reviews · doi:10.1002/med.21432 · Cited by 43
Mouro, F. M., Batalha, V. L., Ferreira, D. G., Coelho, J. E., Baqi, Y., Müller, C. E., Lopes, L. V., Ribeiro, J. A., & Sebastião, A. M. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.02.021 · Cited by 44
Self-citationMitochondria: A Connecting Link in the Major Depressive Disorder Jigsaw
Sharma, S., & Akundi, R. S. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180302120322 · Cited by 44
Kerkhofs, A., Canas, P. M., Timmerman, A., Heistek, T. S., Real, J. I., Xavier, A. C., Cunha, R. A., Mansvelder, H. D., & Ferreira, S. G. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00133 · Cited by 45
Self-citationChen, P.-Z., He, W., Zhu, Z.-R., Guoji, E., Xu, G., Chen, D., & Gao, Y. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.02.038 · Cited by 41
Signaling pathways underlying the antidepressant-like effect of inosine in mice
Gonçalves, F. M., Neis, V. B., Rieger, D. K., Lopes, M. W., Heinrich, I. A., Costa, A. P., Rodrigues, A. L. S., Kaster, M. P., & Leal, R. B. (2016) · Purinergic Signalling · doi:10.1007/s11302-016-9551-2 · Cited by 41
Self-citationKerkhofs, A., Xavier, A. C., da Silva, B. S., Canas, P. M., Idema, S., Baayen, J. C., Ferreira, S. G., Cunha, R. A., & Mansvelder, H. D. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00899 · Cited by 43
Self-citationPadilla, K., Quintanar‐Stephano, A., López-Vallejo, F., Berumen, L. C., Miledi, R., & García‐Alcocer, G. (2018) · Brain and Behavior · doi:10.1002/brb3.952 · Cited by 40
Gomes, J. I., Farinha‐Ferreira, M., Rei, N., Gonçalves‐Ribeiro, J., Ribeiro, J. A., Sebastião, A. M., & Vaz, S. H. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105363 · Cited by 42
Dias, L., Lopes, C. R., Gonçalves, F. Q., Nunes, A. F., Pochmann, D., Machado, N. J., Tomé, Â. R., Agostinho, P. M., & Cunha, R. A. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.639322 · Cited by 42
Self-citationLiu, Q., Deng, R., Fan, Y.-Y., Li, K., Meng, F., Li, X., & Liu, R. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600910 · Cited by 39
Neis, V. B., Moretti, M., da Rosa, P. B., Dalsenter, Y. D. O., Werle, I., Platt, N., Kaufmann, F. N., Rosado, A. F., Besen, M. H., & Rodrigues, A. L. S. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.173020 · Cited by 39
Self-citationA2A Adenosine Receptor Antagonists in Neurodegenerative Diseases
Merighi, S., Borea, P. A., Varani, K., Vincenzi, F., Jacobson, K. A., & Gessi, S. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666211129122550 · Cited by 38
Stazi, M., Lehmann, S., Sakib, M. S., Pena‐Centeno, T., Büschgens, L., Fischer, A., Weggen, S., & Wirths, O. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-04062-8 · Cited by 42
Adenosine A2Areceptors facilitate synaptic NMDA currents in CA1 pyramidal neurons
Mouro, F. M., Rombo, D. M., Dias, R. B., Ribeiro, J. A., & Sebastião, A. M. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14497 · Cited by 38
Lin, Y.-S., Weibel, J., Landolt, H., Santini, F., Meyer, M., Brunmair, J., Meier, S. M., Gerner, C., Borgwardt, S., Cajochen, C., et al. (2021) · Cerebral Cortex · doi:10.1093/cercor/bhab005 · Cited by 35
Pérez-Ara, M. Á., Gili, M., Visser, M., Penninx, B. W. J. H., Brouwer, I. A., Watkins, E. R., Owens, M., Garcı́a-Toro, M., Hegerl, U., Kohls, E., et al. (2020) · Nutrients · doi:10.3390/nu12103202 · Cited by 35
Duarte, J. M., Gaspar, R., Caetano, L. R. O., Patrício, P., Soares‐Cunha, C., Mateus‐Pinheiro, A., Alves, N. D., Santos, A. R., Ferreira, S. G., Sardinha, V. M., et al. (2018) · Glia · doi:10.1002/glia.23476 · Cited by 38
Self-citationMallik, S. B., Mudgal, J., Hall, S., Kinra, M., Grant, G. D., Nampoothiri, M., Anoopkumar‐Dukie, S., & Arora, D. S. (2021) · Nutritional Neuroscience · doi:10.1080/1028415x.2021.1906393 · Cited by 35
Rajasundaram, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00402 · Cited by 37
Baba, Y., Inagaki, S., Nakagawa, S., Kobayashi, M., Kaneko, T., & Takihara, T. (2021) · Nutrients · doi:10.3390/nu13051700 · Cited by 33
Treviño, S., Vázquez‐Roque, R. A., López‐López, G., Perez‐Cruz, C., Morán, C., Handal‐Silva, A., Vergara, E. G., Flores, G., Guevara, J., & Díaz, A. (2017) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2017.02.007 · Cited by 34
Metadata
- Authors
- Kaster, M. P., Machado, N. J., Silva, H. B., Nunes, A., Ardais, A. P., Santana, M., Baqi, Y., Müller, C. E., Rodrigues, A. L. S., Porciúncula, L. O., Chen, J. F., Tomé, Â. R., Agostinho, P., Canas, P. M., & Cunha, R. A.
- Affiliations
- Universidade Federal de Santa Catarina (BR)
- Centro de Neurociências e Biologia Celular (PT)
- Universidade Federal do Rio Grande do Sul (BR)
- University of Bonn (DE)
- Boston University (US)
- University of Coimbra (PT)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2015-06-08
- Volume
- 112
- Issue
- 25
- Pages
- 7833-7838
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC4485143
- OpenAlex
- W1591120748
- Cited by
- 312
- References
- 48
- Citations by year
- 2026: 24 · 2025: 28 · 2024: 23 · 2023: 26 · 2022: 33 · 2021: 36 · 2020: 26 · 2019: 29 · 2018: 41 · 2017: 19 · 2016: 17 · 2015: 10
- FWCI
- 13.53
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Brain and Behavior Research Foundation (2014 NARSAD INDEPENDENT INVESTIGATOR GRANT)
- DOD | Defense Advanced Research Projects Agency (W911NF-10-1-0059)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- caffeine, adenosine A2A receptor, chronic unpredictable mild stress, depression, anxiety, memory impairment, hippocampus, synaptic plasticity, glutamatergic terminals, SNAP-25, syntaxin, VGLUT1, adenosine A2A receptor antagonists, neuroprotection
- MeSH terms
- Animals, Caffeine, Male, Memory Disorders, Mice, Inbred C57BL, Neurons, Stress, Psychological, Mood Disorders, Receptor, Adenosine A2A, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review